Related Experiment Video
Updated: Aug 8, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein
John C Cooper1, Jared N Boustead, Chao-Lan Yu
1Department of Molecular Physiology and Biophysics, Room 813B Light Hall, Vanderbilt University School of Medicine, Nashville, TN 37232-0615, USA.
Abstract:
Cytokine-inducible SH2-containing protein (CIS) is the first identified member of genes encoding for the suppressor of cytokine signaling (SOCS). CIS is also a well-known target gene of signal transducer and activator of transcription 5 (STAT5) pathways, providing normal negative feedback control of signaling by cytokines and growth factors. Three other SOCS genes, SOCS1, SOCS2, and SOCS3, can be silenced by DNA hypermethylation in human cancers, suggesting a potential mechanism for constitutive STAT activation. However, it is not known whether CIS expression is similarly perturbed in tumor cells. We report here the absence of CIS expression in T lymphoma LSTRA that overexpresses the Lck protein tyrosine kinase and exhibits elevated STAT5 activity. Pervanadate-induced CIS expression and STAT5 binding to the CIS promoter in vivo over a short time course implies that mechanisms other than DNA hypermethylation may contribute to defective CIS expression in LSTRA cells. Comparison with cytokine-dependent BaF3 cells stimulated with interleukin-3 (IL-3) further reveals that CIS induction correlates with specific STAT5b post-translational modifications. It exhibits as the slowest migrating form through SDS-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. This distinctly modified STAT5b is the predominant form that binds to the consensus STAT5 sites in the CIS promoter and accumulates in the nucleus. In vitro phosphatase assays and phosphoamino acid analysis suggest the involvement of phosphorylation on residues other than the highly conserved tyrosine and serine sites in this distinct STAT5b mobility shift. All together, our results provide a novel link between incomplete STAT5b phosphorylation and defective SOCS gene expression in cancer cells.
Insights
Defective expression of Cytokine-inducible SH2-containing protein (CIS) in cancer cells is linked to altered STAT5b phosphorylation. This finding suggests new mechanisms beyond DNA hypermethylation impacting gene expression in tumors.
Area of Science:
- Molecular Biology
- Cancer Research
- Signal Transduction
Background:
- Cytokine-inducible SH2-containing protein (CIS) is a key negative regulator in cytokine signaling pathways.
- Other suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation in cancer, leading to uncontrolled STAT activation.
- The regulation of CIS expression in tumor cells remains largely uncharacterized.
Purpose of the Study:
- To investigate the expression status of CIS in T lymphoma cells with elevated STAT5 activity.
- To explore the mechanisms underlying potential defects in CIS gene expression in cancer.
- To identify novel post-translational modifications of STAT5b influencing CIS gene regulation.
Main Methods:
- Analysis of CIS expression in LSTRA T lymphoma cells and BaF3 cells.
- Assessment of STAT5 binding to the CIS promoter using in vivo assays.
- SDS-polyacrylamide gel electrophoresis (SDS-PAGE) for STAT5b modification analysis.
- In vitro phosphatase assays and phosphoamino acid analysis.
Main Results:
- CIS expression was absent in LSTRA T lymphoma cells with high STAT5 activity.
- CIS induction in response to IL-3 in BaF3 cells correlated with specific STAT5b post-translational modifications.
- A distinct, slowly migrating form of STAT5b, associated with nuclear accumulation and promoter binding, was identified.
- Phosphorylation on non-canonical sites of STAT5b was implicated in this mobility shift.
Conclusions:
- Defective CIS expression in cancer cells may involve mechanisms other than DNA hypermethylation.
- Specific STAT5b post-translational modifications, potentially involving non-canonical phosphorylation, are critical for CIS gene induction.
- This study reveals a novel link between aberrant STAT5b phosphorylation and impaired SOCS gene expression in the context of cancer.
More Related Videos
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway

